You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 44 No. 2, February 1942 TABLE OF CONTENTS
  Archives
  •  Online Features
  SYMPOSIUM ON CHEMOTHERAPY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

BACTERIOSTATIC PROPERTIES OF SULFANILAMIDE AND SOME OF ITS DERIVATIVES

I. SUCCINYLSULFATHIAZOLE, A NEW CHEMOTHERAPEUTIC AGENT LOCALLY ACTIVE IN THE GASTROINTESTINAL TRACT

EDGAR J. POTH, M.D., Ph.D.; F. LOUIS KNOTTS, M.D.; JAMES T. LEE, M.D.; FRANK INUI, M.D.

Arch Surg. 1942;44(2):187-207.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A systematic study to find a satisfactory drug to alter the bacterial flora of the intestinal tract was undertaken after it became apparent that sulfanilylguanidine has a limited application in the surgical treatment of diseases of the gastrointestinal tract. Sulfanilylguanidine, according to the original reports of Marshall, Bratton, White and Litchfield1 and Firor and Jonas,2 seemed to offer great possibilities in this field. However, additional experience presented by Firor and Poth3 showed that this drug is not satisfactory because (1) the drug is too readily absorbed from the gastrointestinal tract, giving rise to frequent and occasionally severe reactions, and (2) is ineffectual in the presence of ulcerating lesions of the bowel.

The present investigation was undertaken to find an active drug which is not absorbed from the gastrointestinal tract in sufficient quantities to cause toxic manifestations and which is effective in the presence of ulcerating lesions of . . . [Full Text PDF of this Article]


Author Affiliations

BALTIMORE

From the Department of Surgery, Johns Hopkins University School of Medicine.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1942 American Medical Association. All Rights Reserved.